Page last updated: 2024-09-04

pomalidomide and ML162

pomalidomide has been researched along with ML162 in 1 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(ML162)
Trials
(ML162)
Recent Studies (post-2010) (ML162)
6231215521106

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)ML162 (IC50)
fatty acid synthaseHomo sapiens (human)10.4
Phosphatidylinositol 3-kinase catalytic subunit type 3Homo sapiens (human)0.0215

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ge, J; Hu, S; Jiang, L; Yan, X; Yao, SQ; Zeng, Q; Zhang, B; Zhu, L1

Other Studies

1 other study(ies) available for pomalidomide and ML162

ArticleYear
Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4.
    Bioorganic chemistry, 2023, Volume: 134

    Topics: Cell Cycle; Cell Proliferation; Phospholipid Hydroperoxide Glutathione Peroxidase; Proteolysis; Proteolysis Targeting Chimera

2023